• Chan Beals, Calibr-Skaggs Institute for Innovative Medicines

    Chief Medical Officer

    "Partnering with FGK has been instrumental in advancing our clinical programs. Their expertise, dedication, and high-quality execution across multiple projects provided the strong foundation we needed to achieve key milestones. The success of these studies directly contributed to an outcome that would not have been possible without their exceptional support. We truly value this collaboration.”